Skip to main content
. 2024 Jul 30;2(1):e000975. doi: 10.1136/bmjph-2024-000975

Table 3. Comparison of costs of wheezing episodes by age group.

Costs Wheezing episodes after severe RSV-ALRTI
Total episodesN=429 0–12 months(n=177) 12–24 months(n=152) >24 months(n=100) P value
Laboratory cost
 Mean 1.90 3.25 0.89 1.04 0.0004
 95% CI 1.33 to 2.46 2.05 to 4.45 0.41 to 1.37 0.20 to 1.88
Staff cost
 Mean 98.89 153.58 62.24 57.79 0.000
 95% CI 79.02 to 118.76 111.43 to 195.72 42.86 to 81.62 33.85 to 81.74
Drug cost
 Mean 8.31 8.31 7.51 9.54 0.072
 95% CI 7.66 to 8.96 7.31 to 9.31 7.05 to 7.96 7.46 to 11.62
Feeding cost*
 Mean 5.32 7.42 3.35 4.60 0.153
 95% CI 3.48 to 7.16 4.31 to 10.53 0.74 to 5.96 0.47 to 8.72
Imaging diagnostic cost
 Mean 4.39 5.01 3.55 4.58 0.142
 95% CI 3.75 to 5.04 3.85 to 6.17 2.67 to 4.43 3.31 to 5.85
Supplies cost
 Mean 1.46 1.69 0.90 1.89 0.117
 95% CI 1.06 to 1.85 1.01 to 2.37 0.40 to 1.39 0.94 to 2.84
Oxygen cost
 Mean 10.59 17.46 6.43 4.74 0.0002
 95% CI 7.83 to 13.35 11.57 to 23.35 3.37 to 9.49 2.26 to 7.22
Facilities cost
 Mean 10.25 10.18 9.59 11.38 0.523
 95% CI 9.09 to 11.41 8.36 to 12.00 8.96 to 10.23 7.65 to 15.11
Equipment cost
 Mean 0.45 0.53 0.37 0.44 0.091
 95% CI 0.39 to 0.51 0.42 to 0.64 0.28 to 0.46 0.31 to 0.57
Total cost
 Mean 141.56 207.43 94.84 96.00 0.0001
 95% CI 116.22 to 166.90 154.29 to 260.57 69.47 to 120.20 62.43 to 129.57

Bold values represent a p value less than 0.05

RSV-ALRTIrespiratory syncytial virus–acute lower respiratory tract infection